Clinical trial
Correction of Anaemia and Progression of Renal Failure on Transplanted Patients
NCT00396435 · Centre Hospitalier Universitaire, Amiens, Other · Completed
Key facts
| NCT number | NCT00396435 |
|---|---|
| Title | Correction of Anaemia and Progression of Renal Failure on Transplanted Patients |
| Official title | Multicenter, Prospective, Randomised, Open-label Study, Evaluating the Effect of Two Levels of Haemoglobin on Quality of Life and Speed of Progression of Renal Insufficiency on Renal Transplanted Patients With Chronic Graft Dysfunction (CGD) |
| Lead sponsor | Centre Hospitalier Universitaire, Amiens, Other |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anaemia, Renal Transplantation, Kidney Failure |
| Intervention type | Drug |
| Interventions | Neorecormon |
| Enrollment | 128 |
| Start date | Apr 1, 2004 |
| Primary completion | Apr 1, 2009 |
| Completion | May 1, 2010 |
| First posted | Nov 7, 2006 |
| Last update posted | Sep 23, 2025 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: